R ecent studies indicate that hypoxia, a decrease in oxygen tension within tissues, plays an important role in atherosclerosis progression. 1,2 Nourishment of healthy artery walls is achieved by oxygen diffusion from the lumen of the vessel and from adventitial vasa vasorum. As the disease progresses, the arterial wall thickens, and oxygen diffusion into the intima is markedly reduced. 3,4 Moreover, the elevated oxygen consumption and high metabolic rate of infiltrated macrophages and foam cells contribute to impair the oxygenation of the vessel wall. 5,6 Indeed, advanced atherosclerotic plaques show severely hypoxic regions, particularly those containing macrophage-rich areas, in both humans 7 and animal models. 8, 9 Hypoxia, through the activation of the hypoxia-inducible factor (HIF-1), 10 represents an essential signal for plaque growth by inducing critical processes, such as the formation of lipid droplets and 11,12 the activation of a metabolic switch to anaerobic glycolysis, 10,13 and increasing the secretion of proinflammatory and angiogenic mediators. 1, 14 In fact, hypoxia is the most potent stimulus for angiogenesis, predominantly through the activation of the HIF-1/vascular endothelial growth factor (VEGF) pathway, 15 and microvessel density has been shown to increase in inflamed lesions. 16, 17 The recent development of molecular and functional imaging technologies has made it possible to quantify the extent of disease in terms of visualization of some plaque elements related to clinical complications (eg, inflammation, Background-Hypoxia is an important microenvironmental factor influencing atherosclerosis progression by inducing foam-cell formation, metabolic adaptation of infiltrated macrophages, and plaque neovascularization. Therefore, imaging plaque hypoxia could serve as a marker of lesions at risk. Methods and Results-Advanced aortic atherosclerosis was induced in 18 rabbits by atherogenic diet and double balloon endothelial denudation. Animals underwent 18 F-fluoromisonidazole positron emission tomographic and 18 F-fluorodeoxyglucose positron emission tomographic imaging after 6 to 8 months (atherosclerosis induction) and 12 to 16 months (progression) of diet initiation. Four rabbits fed standard chow served as controls. Radiotracer uptake of the abdominal aorta was measured using standardized uptake values. After imaging, plaque hypoxia (pimonidazole), macrophages (RAM-11), neovessels (CD31), and hypoxia-inducible factor-1α were assessed by immunohistochemistry. 18 Ffluoromisonidazole uptake increased with time on diet (standardized uptake value mean, 0.10±0.01 in nonatherosclerotic animals versus 0.20±0.03 [P=0.002] at induction and 0.25±0.03 [P<0.001] at progression). Ex vivo positron emission tomographic imaging corroborated the 18 F-fluoromisonidazole uptake by the aorta of atherosclerotic rabbits. 18 F-fluorodeoxyglucose uptake also augmented in atherosclerotic animals, with an standardized uptake value mean of 0.43±0.02 at induction versus 0.35±0.02 in nonatherosclerotic animals (P=0.031) and no further increase at progression. By immunohistochemistry, hypoxia was mainly located in the macrophage-rich areas within the atheromatous core, whereas the macrophages close to the lumen were hypoxia-negative. Intraplaque neovessels were found predominantly in macrophage-rich hypoxic regions (pimonidazole + /hypoxia-inducible factor-1α + /RAM-11 + ). Conclusions-Plaque hypoxia increases with disease progression and is present in macrophage-rich areas associated with neovascularization. 18 F-fluoromisonidazole positron emission tomographic imaging emerges as a new tool for the detection of atherosclerotic lesions. (Circ Cardiovasc Imaging. 2014;7:312-320.)
neovascularization). 18 Among them, positron emission tomography (PET) with 18 F-fluorodeoxyglucose ( 18 F-FDG) has emerged as 1 of the most promising imaging modalities to assess inflamed (and likely at risk) atherosclerotic plaques because of its predominant uptake by cells with enhanced glucose metabolism, such as plaque macrophages. [19] [20] [21] However, the factors that determine 18 F-FDG uptake in atherosclerotic plaques are not fully understood 22 ; a recent study has suggested that 18 F-FDG uptake in atheroma may be the result of the hypoxic activation of glucose uptake in macrophages rather than mere inflammatory burden. 23 Therefore, given the essential role of hypoxia/HIF-1 in inflammation and neovascularization, hypoxia may represent a novel target for noninvasive imaging of atherosclerotic plaque at risk.
At present, PET is the most suitable method for in vivo noninvasive clinical assessment of hypoxia. 24,25 18 F-fluoromisonidazole ( 18 F-FMISO) is 1 of the leading PET radiotracers for imaging hypoxia, and it has been successfully used to image ischemic stroke, 26 myocardial ischemia, 27 and a wide variety of malignancies. 24 18 F-FMISO is a cell-permeable 2-nitroimidazole derivative that is reduced in vivo by nitroreductases regardless of the intracellular oxygen concentration. Under normal oxygenation conditions, 18 F-FMISO is rapidly reoxidized and diffuses out the cells. However, in hypoxic viable cells, 18 F-FMISO is further reduced to a more reactive form that binds covalently to intracellular macromolecules and remains in the cells. This biochemical process exhibits a sharp increase when the partial pressure of oxygen drops <10 mm Hg (≈1.5% O 2 ), which makes it a good marker of hypoxia in the pathological range. Although 18 F-FMISO biodistribution properties do not result in high contrast images, they result in images that unambiguously reflect regional partial pressure of oxygen. 25 The aim of this study was to evaluate the feasibility of 18 F-FMISO PET imaging for in vivo detection of hypoxia in advanced lesions in a rabbit atherosclerosis model and to compare it with the more established 18 F-FDG PET imaging of inflammation/metabolic activity. Hypoxia was confirmed with pimonidazole, the gold standard immmunohistochemical hypoxia marker, and correlated with macrophage content, neovessels count, and the expression of the hypoxia-inducible transcription factor (HIF-1α).
Methods
A full Methods section is available in the Data Supplement.
Animal Protocol
Aortic atherosclerosis was induced in New Zealand white male rabbits (n=18; mean weight 3.1±0.2 kg; Covance) by a combination of atherogenic diet (0.2% cholesterol, Research Diets Inc) and double balloon endothelial denudation. 28 All procedures were performed under general anesthesia by intramuscular injection of ketamine (30 mg/kg; Fort Dodge Animal Health) and xylazine (5 mg/kg; Bayer Corp). Four rabbits fed standard chow and without balloon denudation served as controls. To evaluate the disease progression, we established 3 longitudinal experimental conditions: control (nonatherosclerotic animals); atherosclerosis induction, at 6 to 8 months after initiation of the atherogenic diet; and atherosclerosis progression, at 12 to 16 months of diet initiation. The study design is summarized in the Figure in the Data Supplement (see Materials in the Data Supplement). The animal protocol was approved by the Institutional Animal Care and Use Committee of the Icahn School of Medicine at Mount Sinai. 18 F-FDG PET images were acquired using a combined PET/computed tomography (CT) scanner (Discovery LS, GE Healthcare). A low-dose CT was used for anatomic coregistration and for attenuation correction of the PET data set. Images were acquired 3 hours after injection of 148 to 185 MBq (4-5 mCi) of 18 F-FDG. 21 Acquisition was performed for 15 minutes in 2D mode. 18 F-FMISO PET images were acquired with the sequential whole-body PET/MR system Philips Ingenuity TF (Philips Healthcare). PET images were acquired 3 hours after injection of 148 to 185 MBq of 18 F-FMISO. 29 Acquisition was performed for 30 minutes in 3D mode.
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Magnetic Resonance and CT Imaging
Before the PET imaging sessions, animals were scanned with magnetic resonance imaging (MRI) using the Philips Achieva 3T X-series scanner (Philips Healthcare). T2-weighted turbo spin echo sequences were acquired to provide high-resolution anatomic detail.
Ex Vivo 18 F-FMISO PET Imaging
Immediately after the final in vivo 18 F-FMISO PET session, 6 animals (1 control and 5 atherosclerotic rabbits at the end of the longitudinal study) were euthanized, and the aortas were harvested for ex vivo 18 F-FMISO PET imaging using the PET/MRI scanner described previously. Thereafter, the aortas were processed for histological analysis (see section below).
PET Quantification
PET, MRI, and CT images were automatically coregistered using the Extended Brilliance Workstation (Philips Healthcare). For in vivo PET image analysis, circular regions of interest (ROIs) encompassing the vessel wall were manually drawn on the corresponding axial CT images to cover the whole abdominal aorta using OsiriX Imaging Software. ROIs were quantified using the standardized uptake values (SUV). SUVmean and SUVmax were calculated by averaging ROIs mean and maximum SUVs, respectively, through the entire abdominal aorta. For the ex vivo images, circular ROIs of 1 cm 2 were placed on the T1-weighted sequence used for attenuation correction. Ex vivo image quantification was provided using SUVmean and SUVmax from the ROIs.
Histology and Immunostaining
On the day of the final imaging session, the hypoxia marker pimonidazole hydrochloride (60 mg/kg; Hypoxyprobe Inc) was injected intravenously 2 hours before euthanizing the animals. After imaging, rabbits were euthanized, and the aortas were fixed overnight in 10% buffered-formalin. Serial sections (5-μm thick) were obtained and stained with hematoxylin-eosin. Additional serial sections were assessed for hypoxia, macrophages, neovessels, and HIF-1α using mouse monoclonal antibodies against pimonidazole (MAb1, Hypoxyprobe Inc), antirabbit macrophage (clone RAM-11, Dako), anti-CD31 (clone JC70A, Dako), and anti-HIF-1α (clone H1α67, Novus Biologicals), respectively.
Statistical Analysis
Data are presented as mean±SEM. Analyses were performed using GraphPad Prism (GraphPad Software Inc). The validity of normal distribution assumptions was assessed with the Kolmogorov-Smirnov test. For the in vivo PET data, group differences were tested by either an unpaired t test with the Welch correction to compare control group versus induction and progression or by a paired t test to compare paired data from the same animals (induction versus progression). An unpaired t test was used to compare the histological quantifications. When indicated, Pearson correlations were estimated. P<0.05 was considered statistically significant.
Results
MRI Monitoring of Aortic Atherosclerosis
All the animals underwent an MRI before each PET study for in vivo anatomic monitoring of the disease. T2-weighted MRI showed marked wall thickening of the aortic wall after the atherosclerosis induction period, as compared with the MRI control in nonatherosclerotic animals, and confirmed the development of aortic atherosclerosis with time on diet ( Figure 1 ).
Detection of Hypoxia in Aortic Atherosclerosis by 18 F-FMISO PET
In vivo 18 F-FMISO PET scans demonstrated areas of hypoxia evidenced by a significant increase in the uptake of the radiotracer along the abdominal aorta of the rabbits after the atherosclerosis induction period (average SUVmean of 0.20±0.03, n=16) in comparison with healthy animals (average SUVmean of 0.10±0.01, n=4; P=0.002). Importantly, the uptake of 18 F-FMISO continued to strengthen with time on atherogenic diet until reaching an SUVmean of 0.25±0.03 (n=12) at the end of the feeding period (progression; ≈150% increase over control group; P<0.001). Figure 2 shows representative images of 18 F-FMISO PET/CT scans at the different feeding periods and the radiotracer uptake quantification.
Immediately after the in vivo PET imaging, some animals were euthanized, and their aortas were extracted for ex vivo determination of 18 F-FMISO uptake using PET/MR scanning. As shown in Figure 3 , 18 F-FMISO uptake was dramatically increased in the abdominal aortas from atherosclerotic rabbits (SUVmean of 9.3±2.0×10 −3 at the end of the feeding period) in comparison with negligible uptake in control. Importantly, atherosclerotic plaques showing strong 18 F-FMISO uptake contained intense hypoxic areas on corresponding histological sections, as identified by the presence of hypoxia-specific pimonidazole adducts in the artery wall ( Figure 3D ).
We also measured 18 F-FDG uptake in parallel to 18 F-FMISO. 18 F-FDG uptake increased significantly in the abdominal aortas of atherosclerotic rabbits, with average SUVmean of 0.43±0.02 (n=16) after the atherosclerosis induction period versus 0.35±0.02 (n=4) in control animals (P=0.031). However, the magnitude of 18 F-FDG uptake did not change by the end of the feeding period, with an average SUVmean of 0.43±0.02 (n=12; P=0.046 versus control). Figure 4 shows representative images of 18 F-FDG PET/CT scans at the different feeding periods and the radiotracer uptake quantification.
We correlated the global uptake of 18 F-FMISO and 18 F-FDG in the abdominal aorta of corresponding animals and time points. We found a poor positive correlation between the 2 PET modalities that did not reach statistical significance, at both induction (r=0.29, P=0.27) and progression (r=0.43, P=0.14; Figure 4D ). Examples of studies performed within a few days of each other showing corresponding planes of FDG and FMISO images at the level of the abdominal aorta in coronal projection are given in Figure 4C .
Immunohistochemical analysis showed that hypoxia, as shown by pimonidazole staining, was located predominantly in the deep macrophage-rich areas within the atheromatous core of the plaque. Interestingly, the superficial macrophages adjacent to the lumen were negative or much more weakly stained with pimonidazole ( Figure 5A ). Hypoxia was not detected in noninflamed plaques or in plaques with only superficially infiltrated macrophages, irrespective of the time on diet ( Figure 5B ).
Similarly to the in vivo findings, the hypoxic area of the abdominal aorta was significant after the atherosclerosis induction period, and that trend continued up to the end of the feeding period, whereas macrophage density was fairly stable after the induction period. Figure 5C summarizes the staining quantification. Also, we found a strong correlation between the hypoxic area (pimonidazole + ) and the RAM-11 + -macrophage density of the plaque (r=0.87, P<0.0001; Figure 5D ).
Hypoxia, Macrophages, and Neovascularization of Advanced Atherosclerotic Plaque
In clear concordance with the increase in plaque hypoxia, we observed an increase in plaque neovascularization (media and intima) with the time on atherogenic diet, as determined by CD31 immunostaining. Whereas microvessels were essentially absent in the artery wall of healthy animals, we found an average of 50±24 neovessels per section after the atherosclerotic induction period and 80±17 neovessels per section by the end of the feeding period ( Figure 6 ). Neovessels were mainly detected in the media and at the base of the plaque, in the macrophage-rich hypoxic regions of the thickened intima. Also, in the most advanced lesions, we observed plexuses of neovascularization developing in hypoxic areas at the junction between the intima and media ( Figure 6C ). Remarkably, most of the microvessels found in the tunica media were not associated with hypoxia or macrophages, whereas the neovessels of the intima were typically associated with hypoxic macrophages (pimonidazole + /RAM-11 + regions) or were developing toward hypoxic regions of the thickened intima ( Figure 6 ). Electron microscopy confirmed the presence of microvessels in the intima, predominantly at the base of the plaque, surrounded by cells filled with lipid droplets, mainly macrophages and smooth muscle foam cells ( Figure 6D ).
Because neoangiogenesis is the major response to hypoxia through the activation of the HIF-1, we also determined the expression of HIF-1α. We found that HIF-1α was expressed by nearly all macrophages present in the plaque regardless of their oxygenation state (pimonidazole + /RAM-11 + and pimonidazole -/RAM-11 + regions), indicative of the expression of HIF-1α by hypoxia-dependent and hypoxia-independent mechanisms. However, neovascularization of the plaque (tunica intima) took place almost exclusively in regions containing hypoxic macrophages (pimonidazole + /HIF-1α + /RAM-11 + ) and was barely found at sites containing nonhypoxic macrophages, despite the expression of HIF-1α ( Figure 7) .
Discussion
Hypoxia has been demonstrated in atherosclerotic arteries using different invasive techniques: directly, with polarographic oxygen microelectrodes 3, 4 ; and indirectly, by immunohistochemistry and autoradiography using exogenous hypoxia probes that form stable adducts with intracellular macromolecules under low oxygenation conditions, mainly nitroimidazole derivatives, 7, 8, 30 or by measuring endogenous molecular markers whose expression is associated with hypoxia (HIF-1α, VEGF, hexokinase, glucose transporters). 7, 9, 23, 31 However, these techniques have important limitations, predominantly their invasiveness, but also the limited sampling size and the inability to perform repetitive measurements in patients. Therefore, noninvasive techniques that allow serial imaging of hypoxia in arteries could provide valuable information on disease status, lesions severity, and monitoring of therapeutic interventions.
There is increasing interest in PET for detection of cellular and molecular targets because it is currently the most sensitive and quantitative noninvasive clinical imaging technology. The emergence of new radiotracers has allowed noninvasive assessment of hypoxia, with 18 F-FMISO being the most widely investigated and validated radiotracer. 24, 25 In this study, we have demonstrated the feasibility of in vivo PET imaging with 18 F-FMISO for noninvasive visualization and quantification of plaque hypoxia in an experimental model of advanced atherosclerosis. We observed significant 18 the aortas of atherosclerotic animals compared with healthy ones, and the uptake increased over time with atherogenic diet, suggesting hypoxia as a good biomarker of disease progression. The in vivo detection of hypoxia was convincingly corroborated by ex vivo PET imaging of the excised aorta, which showed areas of strong 18 F-FMISO accumulation in atherosclerotic aortas, as compared with almost absolute absence of uptake in the normal aorta. Importantly, the specificity of the signal originated from the hot spots in the ex vivo PET scans was validated by subsequent immunohistochemical detection of genuine hypoxia with pimonidazole 32 and comparison with less avid uptake regions of same aortas and with nonatherosclerotic aortic segments. In addition, our histological findings demonstrated that hypoxia is present in deep regions of the plaque, always associated with macrophages. However, not all macrophages present in the plaque were hypoxic, and we found that those macrophages located closer to the arterial lumen were much less or not hypoxic at all. These results are in agreement with previous reports in rabbits 8 and humans, 7 suggesting that enough oxygen can diffuse from the lumen to nourish this shallow macrophage population. Furthermore, previous work has shown ATP and glucose depletion as well as lactate accumulation predominantly in the macrophage-rich core of advanced plaques in rabbits, indicative of increased consumption and reduced supply of O 2 and nutrients from the lumen and vasa vasorum to those regions. 5, 6 Whether these 2 macrophage populations, with regard to their oxygenation status, are phenotypically different and have distinct origin and biological functions within the plaque is currently unknown and will need to be explored in future work. Yet FDG remains as the best characterized tracer available for PET imaging, and it has proven valuable for quantifying metabolic activity/inflammation within atherosclerotic lesions in humans and animal models. [19] [20] [21] Thus, this study also aimed to compare both PET modalities in our model of advanced atherosclerosis. As expected, we observed a significant increase of 18 F-FDG uptake by the aortas of atherosclerotic rabbits. However, unlike 18 F-FMISO, the uptake of 18 F-FDG remained stable after 6 to 8 months on diet, with no further increase in the progression group. This was unpredicted because a previous study in the same animal model had shown increased 18 F-FDG uptake by the rabbit aorta throughout the progression of the disease. 28 But several differences between both studies may justify this discrepancy. We scanned 16 rabbits at induction and 12 at progression, in comparison with 8 rabbits at induction and 4 at progression in the previous work, increasing the statistical power of the present study. We also scanned 3 hours after radiotracer injection instead of 30 minutes, reducing considerably the potential for partial volume error; and we imaged the abdominal aorta instead of the thoracic. Furthermore, our histological findings support the in vivo imaging results, which showed an increase of the hypoxic area of the artery wall from induction to progression (≈60%), whereas macrophage density remained almost unchanged (≈15% increase). Given the clinical implications of this finding, additional experiments will be performed to clarify the stabilization of 18 F-FDG uptake in the most advanced stages of the disease.
Importantly, we observed a poor correlation between the global uptake of 18 F-FMISO and 18 F-FDG by the abdominal aorta of atherosclerotic rabbits, despite the good correlation found between hypoxia (pimonidazole) and macrophages (RAM-11) by immunohistology. On the one hand, we must remind that both techniques were scanned with 2 different PET cameras that provide slightly different sensitivity and image resolution. However, this could only have a small and limited impact on quantification because both cameras were properly calibrated to provide absolute quantification parameters. On the other hand, it must be considered that FDG enters the cells through glucose transporters and accumulates in cells with elevated glucose consumption, but it lacks intrinsic specificity for macrophages. Conversely, the mechanism of FMISO uptake and retention makes it specific for hypoxic cells. 33 In oxygen-starved cells, HIF-1 activates transcription of the genes encoding glucose transporters, hexokinase, and other glycolytic enzymes, 10 increasing glycolysis. Given the link between hypoxia and glycolysis, it could be argued that FDG uptake may detect tissue hypoxia as well. Interestingly, a recent study has shown that hypoxia, but not a proatherogenic inflammatory environment, potently stimulated glucose uptake in human macrophages and foam cells. 23 Moreover, other cell types present in the plaque, such as smooth muscle and endothelial cells, markedly increased glucose uptake in a proinflammatory milieu. Therefore, the authors suggested that FDG accumulation in atherosclerotic lesions could be the result, at least partly, of hypoxia-stimulated glycolysis in macrophages rather than an estimate of inflammatory burden. Although we cannot discard that possibility, the significant discrepancy between 18 F-FMISO and 18 F-FDG uptake found here suggests that the 2 tracers do not account for the same biological processes.
It should be underscored that the in vivo 18 F-FMISO PET images of the aorta exhibited much lower contrast compared with the surrounding tissue than those obtained using 18 F-FDG. This is likely because of slow diffusion of 18 F-FMISO into the cells because of the absence of an active uptake mechanism and to the slow clearance of unbound tracer from nonhypoxic areas, resulting in low uptake and reduced image contrast. 25, 33 Contrarily, FDG exhibits high diffusibility, transmembrane carrier-mediated transport, and fast metabolism that results in enhanced image contrast. Although the modest signal-to-noise ratios provided by 18 F-FMISO might pose a drawback for precise local uptake quantification, our study demonstrates that 18 F-FMISO PET is capable of detecting significant differences in the oxygenation of large arteries of an animal the size of a rabbit despite the use of clinical scanners. Therefore, these results show promise for translation to human studies.
In atherosclerosis, plaque angiogenesis is linked to lesion progression and instability. 17, 34, 35 We found that in parallel to the increase in plaque hypoxia, there was an increase in microvessel density throughout disease progression. Neovascularization largely occurred in deep areas of the thickened intima and in the media, with much lower incidence of capillaries in the proximity of the arterial lumen. Hypoxia, through the induction of HIF-1 and the ensuing expression of VEGF, is the primary stimulus for angiogenesis. 15 Recent studies have found a correlation between HIF-1α accumulation and VEGF expression in the plaque, mostly in macrophage-rich areas, in both humans 7, 31, 36 and animal models. 9, 37 Here, we demonstrate that nearly all macrophages present in the plaque expressed HIF-1α, irrespective of their oxygenation state. Nevertheless, intimal neovascularization was almost restricted to regions containing hypoxic macrophages (pimonidazole + /HIF-1α + /RAM-11 + ), which is in clear agreement with the previous work by Sluimer et at 7 in human atherosclerotic carotid plaques. Importantly, we found that neovessels were scarce at sites with nonhypoxic macrophages, despite the expression of HIF-1α. It is well established that stimuli other than hypoxia can induce HIF-1 in normoxia. 38 A variety of atherogenic factors, such as oxidized low-density lipoprotein (oxLDL) and the inflammatory cytokines tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β), are strong inducers of HIF-1 in normoxia. 37, 39, 40 However, the paucity of neovessels in HIF-1α + /pimonidazole − /macrophage-rich regions closer to the lumen stresses the need for additional work to define precisely the mechanisms underlying HIF-1 expression in the plaque and its relation to angiogenesis.
In summary, this is the first study to noninvasively demonstrate plaque hypoxia using in vivo 18 F-FMISO PET imaging in an experimental model of advanced atherosclerosis. We have shown that hypoxia develops in deep areas of advanced plaques, always associated with macrophages, HIF-1α expression, and with intimal neovascularization. Our results demonstrate that plaque hypoxia increases all through the progression of the disease in this experimental model, as revealed by in vivo detection with 18 F-FMISO PET, and immunohistochemical validation with pimonidazole. In contrast to 18 F-FMISO, 18 F-FDG PET showed stabilization of the inflammatory component of the plaque at an earlier stage of the disease. Thus, given the marked association of hypoxic macrophages and neovascularization, critical hallmarks of atherosclerosis progression, plaque hypoxia may represent a novel target for noninvasive imaging of plaques at risk, potentially allowing early diagnosis and risk prediction of patients with atherosclerosis. Nevertheless, human translation will require further work in preclinical models as well as the assessment of additional hypoxia-specific radiotracers.
